BMC Neurol

1. AHMED AM, Mistry N, Gehad AS, Hassan AM, et al
   Inflammatory CADASIL: the cross-link between CADASIL and multiple sclerosis: a report of two cases and systematic review of the literature.
   BMC Neurol. 2026;26:373.
   

   >> Share

   
   

   
   Brain

2. ARNABOLDI PM, Becker J, Nath A, Coyle PK, et al
   Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses.
   Brain. 2026 May 18:awag016. doi: 10.1093.
   

   >> Share

   
   
3. TUR C, Susin-Calle S, Otero-Romero S, Carvajal R, et al
   Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.
   Brain. 2026 Jun 10:awag047. doi: 10.1093.
   

   >> Share

   
   
4. ARLT FA, Miske R, Appeltshauser L, Zinnow V, et al
   Septin multimer autoantibodies in severe motor neuropathy mimicking lower motor neuron disease.
   Brain. 2026 Jun 8:awag183. doi: 10.1093.
   

   >> Share

   
   

   
   Diabet Med

5. KOZUCH W, Dayan R, Ablorsu E, Elker D, et al
   Hypo- and hyperglycaemia following pancreas transplantation for people with type 1 diabetes.
   Diabet Med. 2026 Apr 7:e70307. doi: 10.1111/dme.70307.
   

   >> Share

   
   

   
   Diabetes Res Clin Pract

6. DEEB A, Yaqoob N, Beck RH, Suliman S, et al
   Insulin-to-carbohydrate ratio intensification during Ramadan in young people using advanced hybrid closed-loop therapy: A prospective quasi-experimental pilot study.
   Diabetes Res Clin Pract. 2026;237:113337.
   

   >> Share

   
   
7. GILL S, Grieve N, van Heerden L, Shwed A, et al
   Behaviour change techniques and physical activity outcomes in interventions for children with type 1 diabetes: A scoping review.
   Diabetes Res Clin Pract. 2026;237:113321.
   

   >> Share

   
   
8. KATEEL R, Parida A, Chogtu B, Holla SN, et al
   Safety of GLP-1 receptor agonists in type 1 diabetes: a systematic review and meta-analysis.
   Diabetes Res Clin Pract. 2026;237:113270.
   

   >> Share

   
   

   
   Intern Med

9. IHARA Y, Umeno J, Toh C
   Gastric Polypoid Nodular Scarring Underlying Autoimmune Gastritis.
   Intern Med. 2026 Jun 11. doi: 10.2169/internalmedicine.7304.
   

   >> Share

   
   
10. SAHEKI T, Harada E, Yoshimura T, Kobayashi T, et al
    Development of Graves' Disease and the Recovery of TSH Secretion during a Long-term Follow-up of Isolated TSH Deficiency.
    Intern Med. 2026 Jun 11. doi: 10.2169/internalmedicine.7555.
    

    >> Share

    
    

    
    J Autoimmun

11. SUZUKI S, Iida M, Wakahara T, Shiko Y, et al
    Long-term effectiveness, safety, and cost-effectiveness of intravenous immunoglobulin for generalized myasthenia gravis in an era of molecular targeted drugs: Insights from Japanese post-marketing surveillance.
    J Autoimmun. 2026;162:103588.
    

    >> Share

    
    

    
    J Nephrol

12. KLEIN M, Roberts V, Javaid MM
    Immunoglobulin A nephropathy-novel insights in long-term outcomes and pathophysiology leading to international guideline modification and new emerging therapies.
    J Nephrol. 2026;39:37-49.
    

    >> Share

    
    
13. KRAMER S, Vogt K, Busch M, Schmitt T, et al
    Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria.
    J Nephrol. 2026;39:179-187.
    

    >> Share

    
    
14. SHOU J, Su F, Wang Y, Liao Y, et al
    Beclin-1/LC3B regulation of podocyte autophagy in IgA nephropathy via PI3K/AKT signaling.
    J Nephrol. 2026 Jun 10:aajag006. doi: 10.1093.
    

    >> Share

    
    
15. JAIN A, Pabba M, Pal A, Beers K, et al
    Tumor necrosis factor inhibitor-associated IgA nephropathy in the setting of Behcet's disease: Lessons for the clinical nephrologist.
    J Nephrol. 2026 Jun 8:aajag053. doi: 10.1093.
    

    >> Share

    
    

    
    J Neurol

16. MA LL, Dai K, Ma XM, Liu YY, et al
    Clinical characteristics of late-onset adult autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective cohort study.
    J Neurol. 2026;273:377.
    

    >> Share

    
    
17. XING C, Li W, Tian R, Hu M, et al
    Efgartigimod as adjunctive therapy in refractory autoimmune glial fibrillary acidic protein astrocytopathy: a case series.
    J Neurol. 2026;273:385.
    

    >> Share

    
    
18. GUGER M, Enzinger C, Heschl B, Di Pauli F, et al
    The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.
    J Neurol. 2026;273:392.
    

    >> Share

    
    
19. HOF SN, Keytsman E, Fuchs TAN, Wessels MHJ, et al
    What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.
    J Neurol. 2026;273:355.
    

    >> Share

    
    
20. REUTER E, Luerweg J, Katsimpoura M, Haselon J, et al
    Virtual reality-based oculography detects internuclear ophthalmoplegia in multiple sclerosis and other neurological disorders.
    J Neurol. 2026;273:372.
    

    >> Share

    
    
21. ESPOSITO F, Misra K, Doyle F, Clarelli F, et al
    Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes.
    J Neurol. 2026;273:374.
    

    >> Share

    
    
22. FOTTINGER F, Krajnc N, Berek K, Nolte JP, et al
    Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.
    J Neurol. 2026;273:382.
    

    >> Share

    
    

    
    J Pediatr Endocrinol Metab

23. OZTURK IS, Gurbuz F, Ugras E
    Psychosocial adaptation of parents of children with type 1 diabetes: a cross-sectional study.
    J Pediatr Endocrinol Metab. 2026;39:449-456.
    

    >> Share

    
    

    
    J Rheumatol

24. ELOSEILY E, Romankevych I, Sabit T, Berklite L, et al
    Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
    J Rheumatol. 2026;53:669-678.
    

    >> Share

    
    

    
    Mult Scler

25. MCCURDY S, Sheng E, Jalaleddini K, Datta G, et al
    Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS.
    Mult Scler. 2026;32:711-721.
    

    >> Share

    
    
26. TALLANTYRE EC, Apap Mangion S, Teunissen CE
    A framework for blood biomarker discovery in MS.
    Mult Scler. 2026;32:661-669.
    

    >> Share

    
    
27. CHEN H, Cortese M, Flores-Torres MH, Chen X, et al
    Comorbidities and lifestyle changes as predictors of the multiple sclerosis prodrome: A prospective cohort study.
    Mult Scler. 2026 Jun 10:13524585261454827. doi: 10.1177/13524585261454827.
    

    >> Share

    
    
28. HAMEDANI M, Lombardi G, Boffa G, Pistarini C, et al
    Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.
    Mult Scler. 2026 Jun 9:13524585261450820. doi: 10.1177/13524585261450820.
    

    >> Share

    
    

    
    N Engl J Med

29. BASTARD P, Casanova JL
    Autoantibodies against Cytokines - From Infection to Inflammation.
    N Engl J Med. 2026;394:2270-2273.
    

    >> Share

    
    
30. GHARAHDAGHI N, Yeh PJ, Ceron-Gutierrez L, Griffin H, et al
    Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.
    N Engl J Med. 2026;394:2212-2222.
    

    >> Share

    
    

    
    Neurologia (Engl Ed)

31. MASSONS M, Rodriguez-Vazquez A, Mesa A, Amaro S, et al
    Bilateral carotid arteriopathy associated with Graves Disease: a case report.
    Neurologia (Engl Ed). 2026 May 25:502089. doi: 10.1016/j.nrleng.2026.502089.
    

    >> Share

    
    

    
    Neurology

32. GUINEBRETIERE O, Yang F, Wei D, Calonge Q, et al
    Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).
    Neurology. 2026;107:e218072.
    

    >> Share

    
    

    
    PLoS One

33. MARIKI A, Kohlmeier KA, Mousavi SM, Keyhani A, et al
    Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone -induced multiple sclerosis model.
    PLoS One. 2026;21:e0349675.
    

    >> Share

    
    
34. MARTIN-BAEZ MY, Diaz-Gonzalez CM
    Preschool and primary school teachers' attitudes toward students with type 1 diabetes: A cross-sectional study.
    PLoS One. 2026;21:e0350813.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share